Literature DB >> 19058702

Unilateral transforaminal lumbar interbody fusion (TLIF) using a single cage for treatment of low grade lytic spondylolisthesis.

Mohamed Adel el-Masry1, Hisham Khayal, Hossam Salah.   

Abstract

The authors conducted a prospective study on 30 patients with low grade lytic spondylolisthesis, who underwent unilateral transforaminal lumbar interbody fusion (TLIF) using a single cage with adjunctive pedicular fixation. There were 17 males and 13 females with a mean age of 39.5 years. The mean follow-up period was 32 months. The overall clinical results were excellent or good in 90% of the patients. Fusion was solid or probable in 91%. Three patients presented initially with a motor deficit; one of them did not recover. According to the literature this technique yields a shorter operative time, less blood loss, less need for intensive care, shorter hospital stay, lower hospital cost and less complications than other techniques for interbody fusion. It is safe and reliable in patients with low grade lytic spondylolisthesis.

Entities:  

Mesh:

Year:  2008        PMID: 19058702

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  3 in total

1.  Single transverse-orientation cage via MIS-TLIF approach for the treatment of degenerative lumbar disease: a technical note.

Authors:  Shan-Jin Wang; Ying-Chao Han; Fu-Min Pan; Bin Ma; Jun Tan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  [Interbody fusion procedures. Development from a historical perspective].

Authors:  Marcus Rickert; Michael Rauschmann; C Fleege; E Behrbalk; J Harms
Journal:  Orthopade       Date:  2015-02       Impact factor: 1.087

3.  Analysis of single cage position in transforaminal lumbar interbody fusion through digital images.

Authors:  Xin Zhao; Chen Chen; Tangjun Zhou; Jie Mi; Lin Du; Zhanrong Kang; Jianming Huang; Kai Zhang; Xiaojiang Sun; Jie Zhao
Journal:  Int Orthop       Date:  2018-02-11       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.